Funding for CEPI 2.0's next five-year business cycle 2022-2027
- Funded by Wellcome Trust
- Total publications:0 publications
Grant number: 226066/Z/22/Z
Grant search
Key facts
Disease
Disease XStart & end year
20232028Known Financial Commitments (USD)
$134,241,291.6Funder
Wellcome TrustPrincipal Investigator
Dr. Richard Jones Hatchett IVResearch Location
NorwayLead Research Institution
Coalition for Epidemic Preparedness Innovations (CEPI)Research Priority Alignment
N/A
Research Category
Health Systems Research
Research Subcategory
Medicines, vaccines & other technologies
Special Interest Tags
N/A
Study Type
Not applicable
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
CEPI's 2022-2027 strategic priorities are founded on the three pillars of Prepare, Transform and Connect. CEPI will prepare for known epidemics and pandemic threats by developing vaccines and promising biologics against the most prominent known threats, building on COVID-19 achievements and CEPI 1.0. CEPI will transform the response to the next novel threat by harnessing innovations in technology and systems to significantly reduce the global vulnerability to threats from novel pathogen outbreaks. CEPI will enhance and expand global collaboration by connecting emerging infectious disease stakeholders to enable rapid countermeasure development, effective response and equitable access for those in need. If the products developed with CEPI's funding are to realise their potential, they should flow through a system with pre-agreed governance, financing, allocation, and distribution mechanisms to govern their ultimate use. CEPI is already contributing to and helping shape a post-pandemic consensus, creating a well-prepared ecosystem able to react quickly without leaving anyone behind.